These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 238553)

  • 41. The effects of suxamethonium and pancuronium on the haemodynamic response to endotracheal intubation.
    Khan FA; Kamal RS
    J Pak Med Assoc; 1991 Mar; 41(3):51-4. PubMed ID: 2033780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery.
    Emmott RS; Bracey BJ; Goldhill DR; Yate PM; Flynn PJ
    Br J Anaesth; 1990 Oct; 65(4):480-6. PubMed ID: 1979009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of AH8165 for Caesarian section.
    Cane RD; Sinclair DM
    Anaesthesia; 1976 Mar; 31(2):212-4. PubMed ID: 7152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiopentone and pancuronium crash induction. A comparison with thiopentone and suxamethonium.
    Barr AM; Thornley BA
    Anaesthesia; 1978 Jan; 33(1):25-31. PubMed ID: 626332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Histamine plasma concentration and cardiovascular effects of non-depolarizing muscle relaxants: comparison of atracurium, vecuronium, pancuronium and pipecuronium in coronary surgical patients at risk].
    Brinkmann M; Günnicker M; Freund U; Schieffer M; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):362-6. PubMed ID: 9689393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical experiences with a new muscle relaxant ah 8165--a derivate from azobis-arylimidazo-pyridinium (author's transl)].
    Inoue K; Erdmann W; Stegbauer HP; Frey R
    MMW Munch Med Wochenschr; 1974 Oct; 116(42):1839-44. PubMed ID: 4279331
    [No Abstract]   [Full Text] [Related]  

  • 47. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.
    Meakin GH; Meretoja OA; Perkins RJ; Waite I; Taivainen T; Wirtavuori K; Murphy AK; Raiha L
    Paediatr Anaesth; 2007 Feb; 17(2):113-20. PubMed ID: 17238881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancuronium, vecuronium, and heart rate during anesthesia for aortocoronary bypass operations.
    Mangar D; Turnage WS; Connell GR; Graubert D
    Eur J Cardiothorac Surg; 1993; 7(10):524-7. PubMed ID: 7903545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The new non-depolarizing muscle relaxant ORG NC 45 in clinical anaesthesia: preliminary results.
    Buzello W; Bischoff G; Kuhls E; Nöldge G
    Br J Anaesth; 1980; 52 Suppl 1():62S-64S. PubMed ID: 6107109
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuromuscular blockade for rapid tracheal intubation in children: comparison of succinylcholine and pancuronium.
    Cunliffe M; Lucero VM; McLeod ME; Burrows FA; Lerman J
    Can Anaesth Soc J; 1986 Nov; 33(6):760-4. PubMed ID: 3779499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative clinical study of dioxonium and pancuronium as muscle relaxants in small children.
    Iisalo EU; Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):260-5. PubMed ID: 7030973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of carbon dioxide on the neuromuscular and haemodunamic effects of AH 8265, a new non-depolarizing muscle relaxant.
    Coleman AJ; Walling PT; Downing JW; Bees LT
    Br J Anaesth; 1975 Mar; 47(3):365-9. PubMed ID: 237515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is the optimal remifentanil dosage for providing excellent intubating conditions when coadministered with thiopental? A prospective randomized dose-response study.
    Bouvet L; Stoian A; Rousson D; Allaouchiche B; Chassard D; Boselli E
    Eur J Anaesthesiol; 2010 Jul; 27(7):653-9. PubMed ID: 20442660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conditions for tracheal intubation following fazadinium and pancuronium.
    Corall IM; Ward ME; Page J; Strunin L
    Br J Anaesth; 1977 Jun; 49(6):615-7. PubMed ID: 17427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular effects of pancuronium.
    Brown EM; Smiler BG; Plaza JA
    Anesthesiology; 1973 Jun; 38(6):597-9. PubMed ID: 4267572
    [No Abstract]   [Full Text] [Related]  

  • 57. The value of pancuronium in prolonged intraocular operations.
    Patenaude BL; Robblee JA; Watson AG
    Can J Ophthalmol; 1977 Oct; 12(4):265-7. PubMed ID: 922567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium.
    Gyermek L; Cantley EM
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):600-5. PubMed ID: 7874374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Vecuronium: onset of effect and intubation conditions in comparison to pancuronium and suxamethonium].
    Engel B; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):645-50. PubMed ID: 2869713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical use of vecuronium (ORG NC 45) in balanced anesthesia. Comparison with pancuronium.
    Thomas B; Rolly G; Huylenbroeck G; Beerens J
    Acta Anaesthesiol Belg; 1982; 33(3):167-76. PubMed ID: 6128860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.